Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) currently has a daily average trading volume of 3.47M but it saw 1867104 shares traded in last market. With a market cap of 1.61M USD, the company’s current market price of $0.32 came rising about 6.33 while comparing to the previous closing price of $0.30. In past 52 weeks, the stock remained buoying in the range of price level as high as $6.18 and as low as $0.28. In the recent trading on the day, stock has struck highest price mark of $0.2967 while lowest mark touched by it was $0.325.
Taking a look at 20-day trading activity of Quoin Pharmaceuticals Ltd ADR (QNRX) gives us an average price of $0.3899, while its current price level is -94.84% below from 52-week high level whereas it is 13.48% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5491 while that of 200 days or SMA-200 reads an average of $0.6230. A closer look into the stock’s movement over the week reveals that its volatility is standing at 9.16% during that period while stretching the period over a month that increases to 15.50%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 35.55 which implies that the stock is in neutral territory.
Over the week, QNRX’s stock price is moving 2.57% up while it is -44.19% when we observe its performance for the past one month. Year-to-date it is -50.98% down and over the past year, the stock is showing a downside performance of -90.51%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.43 while estimate for next year EPS is -2.05.
Currently, Quoin Pharmaceuticals Ltd ADR’s total number of outstanding shares is 5.05M with 2.45% of that held by the insiders while 5.89% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -160.77% and return on equity (ROE) at -136.11%. Stock’s beta reads 1.83. Stock has a price to book (P/B) ratio of 0.30. Its return on asset (ROA) is -66.14% on average.
